Individual.com logo
Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Newsdesks
Business
Finance
Internet
Computing
Environmental
Energy
Healthcare
Industry News, A-Z
Sports
Telecom
Transportation
Table bottom

Search
Google News
Table bottom

My Settings
Topics
Companies
Personal Info
Preferences
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Stock Market
Managed Health Care
Commodities & Futures
Freight & Air Courrier
Corporate News
Obesity, Weight Control & Nutrition
Science
Computer Semiconductors
Labor
US Regulation
Table bottom

Antitrust
Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on the new Health and Human Services (HHS) proposal pending at the Office of Management and Budget (OMB): "Removal Of Safe Harbor...
PR Newswire, 12:13pm ET



Asahi Kasei has decided to acquire Sage Automotive Interiors, Inc. (Sage), a US-based manufacturer of automotive interior material, for a cash transaction price of approximately $700 million (¥79.1 billion*1). An agreement...
BusinessWire, 9:08am ET

PLANEGG/MUNICH, GERMANY and MECHELEN, BELGIUM / ACCESSWIRE / July 19, 2018 / MorphoSys AG (NASDAQ: MOR), (FSE: MOR), (XETRA: MOR) announces today that MorphoSys and Galapagos NV have entered into a worldwide, exclusive agreement with Novartis...
ACCESSWIRE, 9:03am ET

Ally Law, a global legal network that includes more than 65-member firms and approximately 2400 lawyers worldwide, is pleased to announce our newest members, Cascione Pulino Boulos & Santos in Brazil, and Hankyul Law Group in South Korea....
PR Newswire, 8:43am ET

Independence Contract Drilling, Inc. (NYSE: ICD) ("ICD") and Sidewinder Drilling, LLC ("Sidewinder") today jointly announced their entry into a definitive merger agreement pursuant to which ICD will acquire all of the outstanding equity...
PR Newswire, 6:38am ET

DGAP-News: MorphoSys AG / Key word(s): Alliance/Change in Forecast MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Pharma Partner (news with additional features) 19.07.2018 / 07:15 The issuer is solely responsible for...
EQS Group AG, 1:23am ET

Novartis International AG / Novartis demonstrates commitment to lead immuno-dermatology by in-licensing IL-17C compound for atopic dermatitis . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the...
Globe Newswire, 1:23am ET

- Exclusive global license agreement with Novartis on MOR106 - MOR106, a monoclonal antibody directed against IL-17C, will be developed further in atopic dermatitis (AtD) and potentially other indications - Up-front payment of...
Globe Newswire, 1:23am ET

DGAP-Ad-hoc: MorphoSys AG / Key word(s): Alliance/Change in Forecast Ad hoc: MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Novartis and MorphoSys Increases its Financial Guidance for 2018 19-Jul-2018 / 07:13 CET/CEST...
EQS Group AG, 1:18am ET

1-9 of 9


Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, Individual.com. No redistribution allowed.